Clever Leaves (CLVRW) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends CLVRW vs. ALVOW, BFRIW, CYTHW, PROCW, SBFMW, ATNFW, SXTPW, ACONW, AIMDW, and DRTSWShould you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include Alvotech (ALVOW), Biofrontera (BFRIW), Cyclo Therapeutics (CYTHW), Procaps Group (PROCW), Sunshine Biopharma (SBFMW), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical" sector. Clever Leaves vs. Alvotech Biofrontera Cyclo Therapeutics Procaps Group Sunshine Biopharma 180 Life Sciences 60 Degrees Pharmaceuticals Aclarion Ainos Alpha Tau Medical Clever Leaves (NASDAQ:CLVRW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and community ranking. Is CLVRW or ALVOW more profitable? Company Net Margins Return on Equity Return on Assets Clever LeavesN/A N/A N/A Alvotech N/A N/A N/A Which has higher earnings & valuation, CLVRW or ALVOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClever Leaves$17.42MN/AN/AN/AN/AAlvotech$391.87MN/AN/AN/AN/A Does the MarketBeat Community prefer CLVRW or ALVOW? Clever Leaves and Alvotech both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformClever LeavesN/AN/AAlvotechN/AN/A Does the media refer more to CLVRW or ALVOW? In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score. Company Overall Sentiment Clever Leaves Neutral Alvotech Neutral SummaryAlvotech beats Clever Leaves on 1 of the 1 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Clever Leaves News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVRW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVRW vs. The Competition Export to ExcelMetricClever LeavesDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.17B$5.14B$9.08BDividend YieldN/A3.04%5.09%4.23%P/E RatioN/A131.2390.1317.19Price / SalesN/A1,981.001,116.25117.05Price / CashN/A10.2543.1037.85Price / BookN/A3.084.784.78Net IncomeN/A$152.21M$120.31M$225.60M Clever Leaves Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVRWClever LeavesN/AN/AN/AN/A$0.00$17.42M0.00296ALVOWAlvotechN/A$2.78+1.1%N/A+48.5%$0.00$391.87M0.004Gap UpBFRIWBiofronteraN/A$0.09-0.1%N/A+340.0%$0.00$35.36M0.0070Positive NewsCYTHWCyclo TherapeuticsN/A$0.13flatN/A-49.4%$0.00$870,725.000.009Positive NewsPROCWProcaps GroupN/A$0.03-16.3%N/A-57.9%$0.00$414.10M0.004,900Positive NewsGap UpSBFMWSunshine BiopharmaN/A$0.22-2.2%N/A+12.8%$0.00$32.96M0.003Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-8.5%N/A+31.6%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.02-50.8%N/A-56.7%$0.00$502,409.000.002Positive NewsGap DownHigh Trading VolumeACONWAclarionN/A$0.03-35.9%N/A-36.1%$0.00$49,289.000.007Positive NewsGap DownAIMDWAinosN/A$0.03-42.9%N/A-89.6%$0.00$40,633.000.0040News CoverageGap UpDRTSWAlpha Tau MedicalN/A$0.20-21.3%N/A+68.4%$0.00N/A0.0080Positive NewsGap Down Related Companies and Tools Related Companies Alvotech Alternatives Biofrontera Alternatives Cyclo Therapeutics Alternatives Procaps Group Alternatives Sunshine Biopharma Alternatives 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Aclarion Alternatives Ainos Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLVRW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clever Leaves With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.